LADENBURG THALMANN FINANCIAL SERVICES INC. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 203 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$15,000
+50.0%
324
+4.5%
0.00%
Q3 2019$10,000
-33.3%
3100.0%0.00%
Q2 2019$15,000
-34.8%
310
-7.2%
0.00%
Q1 2019$23,000
+53.3%
334
+2.8%
0.00%
Q4 2018$15,000
+1400.0%
325
+3150.0%
0.00%
Q3 2018$1,000
-88.9%
10
-93.3%
0.00%
Q1 2017$9,000
+80.0%
150
+18.1%
0.00%
Q2 2016$5,000
-54.5%
127
-53.3%
0.00%
Q1 2016$11,000
-15.4%
272
+34.7%
0.00%
Q4 2015$13,000
-7.1%
202
-1.5%
0.00%
Q3 2015$14,000
-39.1%
205
-2.8%
0.00%
Q2 2015$23,000
+15.0%
2110.0%0.00%
Q1 2015$20,000
+150.0%
211
+197.2%
0.00%
Q4 2014$8,000
+100.0%
710.0%0.00%
Q3 2014$4,000
+33.3%
710.0%0.00%
Q2 2014$3,000710.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders